跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Approved
STANDARD
RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 18, 2021
Approval ID
e82b4b1ae3bc5f3a
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
e82b4b1ae3bc5f3a
Drug Cima Aemps Name
RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Register Number
1211601001
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2021-11-18
Dosage Form
SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose
120 mg/ml
Route Of Administration
VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
CASIRIVIMAB
300 mg
IMDEVIMAB
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 18, 2021
Approval ID
e82b4b1ae3bc5f3a
Type
Standard
Back to CIMA-AEMPS Approvals
